bioRxivNeurosciencePreprint
A Mesoscale Framework for Psychedelic Drug Action in the Human Brain
Rui DaiiD, Rodrigo CofréiD, Christopher TimmermanniD, Robin Lester Carhart-HarrisiD, Anthony G. HudetziD, Zirui HuangiD, George A. MashouriD
Abstract
The mechanism of psychedelic drug action is a dynamic area of neuroscience, with two major lines of investigation: (1) laboratory studies at the molecular and cellular level, and (2) human neuroimaging studies of functional brain networks. Despite considerable progress, there remains insufficient understanding of the link between molecular/cellular substrates of psychedelics and the whole-brain network effects that result. Here we report a study of psychedelic action that focuses on the intermediate spatial scale of local brain regions (<1cm3). We analyzed the effects of classical psychedelics (dimethyltryptamine [DMT], lysergic acid diethylamide [LSD], psilocybin) and non-classical psychedelics (nitrous oxide, ketamine) in humans using functional magnetic resonance imaging. We found that all five drugs reduced regional homogeneity, that is, they disrupted local synchrony, in small-scale brain regions; this disruption occurred extensively in cortical regions and sparsely in subcortical regions. Dynamic analysis of both regional homogeneity and global functional connectivity showed an inverse pattern, with large-scale functional connectivity being enhanced as local synchrony declined. We then conducted dominance analysis to assess the contribution of various neurotransmitter receptors to changes in regional homogeneity. DMT, LSD, and psilocybin showed the 5-HT receptors as the most dominant association; by contrast, regional homogeneity changes attributable to both nitrous oxide and ketamine were most strongly associated with the NMDA receptor. Both neuronal (including interneurons) and non-neuronal cell types were linked to psychedelic-induced changes in synchrony at the level of local brain regions. These data, across five drugs from two drug classes, provide evidence that a diverse set of molecular and cellular events lead to a common outcome of disrupted synchrony in local brain regions, which in turn mediate drug-specific changes in global functional connectivity.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Canonical and Non-Canonical Psychedelic Drugs Induce Common Network Changes in Human Cortex
Rui Dai, Tony E. Larkin, … George A. Mashour·bioRxiv·Oct 14, 2022
- Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology
Kenneth Shinozuka, Katarina Jerotic, … Morten L. Kringelbach·Translational PsychiatryPeer-reviewed·Dec 4, 2024
- Psychedelics Restructure the Global Workspace of Consciousness
Parsa Yousefi, Kenneth Shinozuka, … Pedro A. M. Mediano·bioRxiv·Oct 5, 2026
- Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex
Manesh Girn, Leor Roseman, … R. Nathan Spreng·NeuroImagePeer-reviewed·Apr 25, 2022
- Classic and dissociative psychedelics induce similar hyper-synchronous states in the cognitive-limbic cortex-basal ganglia system
Ivani Brys, Sebastián A. Barrientos, … Pär Halje·Communications BiologyPeer-reviewed·Jul 26, 2023
- Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience.
S. Parker Singleton, Christopher Timmermann, … Amy F. Kuceyeski·Communications BiologyPeer-reviewed·Apr 18, 2025